Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ago Research Gmbh

Clinical trials sponsored by Ago Research Gmbh, explained in plain language.

Trials to join now! 2 Not yet finished but already full! 1

New targeted therapy shows promise for Tough-to-Treat ovarian cancer

Disease control Ongoing

This study tests a drug called mirvetuximab soravtansine in people whose ovarian cancer has come back and has high levels of a protein called folate receptor alpha. The drug delivers a toxin directly to cancer cells. About 136 participants will either get this drug or standard ch…

Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control

Last updated May 22, 2026 13:52 UTC